Navigation Links
Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project
Date:7/31/2008

CAMBRIDGE, Mass., July 31 /PRNewswire/ -- HIV/AIDS and health systems expert Ann Lion Coleman will join Abt Associates as Director for the Health Systems 20/20 project in August 2008. Health Systems 20/20 is the USAID Bureau of Global Health's flagship project working to strengthen health systems by using an integrated approach to address the financing, governance, operational, and capacity constraints to further the use of life-saving priority health services.

Lion Coleman comes to Abt Associates from the Office of the Global AIDS Coordinator (OGAC) where she served as Technical Support Coordinator for the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), as well as United States Government (USG) delegate to the Global Fund Board of Directors.

She has 30 years of experience as a leader and manager of global, regional, and country-level health programs both internationally and domestically. At OGAC, Lion Coleman managed a $30 million portfolio of USG Global Fund technical support contracts and grants with UNAIDS, Roll Back Malaria, Stop TB, Green Light Committee, and Management Sciences for Health.

"We are delighted that Ann is joining us as HS 20/20 expands and moves into its third year. Her experience with the major actors is particularly valuable as international attention to health systems issues increases," said Nancy Pielemeier, Vice President for International Health at Abt Associates.

Previously Lion Coleman worked as Senior Health Advisor for USAID's office of Population and Reproductive Health. She managed the Agency's bureau-wide Capacity Project; oversaw the $250 million portfolio focusing on the strengthening and integration of health systems at a global level; and directed project staffing, strategic planning, and linkages with other global efforts including those at WHO and the World Bank. She also managed USAID's YouthNet project, guiding global activities to improve the reproductive health and HIV/AIDS prevention behaviors of youth. Earlier as Senior Management Advisor at the Program for Appropriate Technology in Health (PATH), she spent seven years as the regional director for Latin America and the Caribbean where she led efforts to improve performance of health care providers in a number of LAC countries.

"I am enthusiastic about joining Abt and USAID's flagship project HS 20/20. We are at a critical time to focus on health system strengthening. As both PEPFAR and the Global Fund efforts reach their next phase of implementation, health systems strengthening is a key priority to the success of the disease-specific global efforts," Lion Coleman explained.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.


'/>"/>
SOURCE Abt Associates
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
2. Front Line Caregiver Coalition Thanks Sens. Conrad, Coleman and Reps. Pomeroy, Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Administrations Damaging Medicare Cuts
3. Richard Greco Joins Mediware Board
4. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
5. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
6. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
7. Nick Childs Joins Grey New York as Director of Content Development
8. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
9. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
10. NASN Joins Partnership to Fight Chronic Disease
11. AstraZeneca Joins Local Walking Movement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... the alternative health care industry, announces Chris Brandl as its New Guest Director. ... vision and purpose to corporations throughout his career. He began his professional career ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear ... work for a company involved in the underground testing of nuclear weapons. Years later, ... Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions ...
(Date:2/27/2017)... ... 2017 , ... Miro is the ultimate smart media center that offers a ... TV shows and much more apps for user exploration. Its innovative acoustic design with ... 1280 x 720 provides crisp images with remarkable clarity and color. The WiFi connection ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... center for hair transplantation therapy, is proud to announce a new informational post ... hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation ...
(Date:2/26/2017)... ... 26, 2017 , ... Today, A' Design Awards & Competition ... Social Design Awards. , The 7th A' Social Design Award is open ... worldwide with realized projects and conceptual works. , The first phase of the ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017  International Biophysics Corporation, a global medical device ... announced a 34% revenue growth in 2016 when compared to ... sales.  This growth was fueled by its AffloVest® sales in ... the expansion of its global sales of surgical product lines. ... "As we enter our 25 th year in delivering ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
(Date:2/27/2017)... February 27, 2017 Leading Countries, Technologies and ... is expected to grow at a CAGR of 8.9% from 2016-2021 ... grow at a CAGR of 9.1% from 2016 to 2027. The ... ... will benefit you Read on to discover how you can ...
Breaking Medicine Technology: